Metronidazol Amino Acid Augments Effects of Hepatic Arterial Occlusion Combined with Radiotherapy in a Rat Liver Tumor Model

GUO Wei-jian,LI Jie,BAI Yong-rui,FENG Yi,ZHUANG Jun-yan,LU Chang-hong,ZHAO Fang,Cai Jian-ming

DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.09.004

2005-01-01

Abstract:OBJECTIVE: To explore if a new radiosensitizer metronidazol amino acid (CM) can augment the effects of hepatic arterial embolization combined with radiotherapy for transplanted cancer in rat liver. METHODS:Walker 256 carcinosarcoma was transplanted into rat liver to establish a liver cancer model. Hepatic arterial ligation (HAL) was used to block the hepatic arterial blood supply, and to simulate hepatic arterial embolization. Rats bearing tumor were divided into four groups: control group, HAL group, HAL combined with radiotherapy (HAL+RT) group, and HAL+RT plus CM ( HAL+RT+CM) group. Changs in tumor volume and tumor growth inhibiting rate after therapy were evaluated, and frozen sections were used to observe the degree of necrosis in tumor. The expression of VEGF mRNA was detected by in situ hybridization. Lung metastasis was observed by paraffin sections. RESULTS:The tumor volumes in HAL+RT group and HAL+RT+CM group were smaller than the volume in the control group,P0.01. Compared with HAL+RT group, the tumor volume in HAL+RT+CM group decreased further but not significantly,P0.05. Compared with the control group, the degree of tumor necrosis increased only in HAL+RT+CM group,P0.05. The expression of VEGF mRNA decreased significantly in HAL+RT group and HAL+RT+CM group compared with the control group,P0.05. There was no significant difference in metastasis rate among the four groups,P0.05. CONCLUSIONS:Introducing CM into the combined therapy with hepatic arterial occlusion and radiotherapy for transplanted cancer in rat′s liver can promote tumor necrosis, and has the trend in reducing tumor volume.However,it has no significant influence on the expression of VEGF and lung metastasis rate.